
Early bird registration is open and closes May 2025. Register now
Abstracts deadline EXTENDED Friday 22 May 2026! Submit now


Title TBC Information coming soon Agenda – Saturday 31 October Chairperson: Seung-Ki Kwok TBC Presentation title TBC Kunihiro Yamaoka

From Inflammation to Impact: Early Treatment Strategies in Spondyloarthritis Agenda – Saturday 31 October Chairperson: Kichul Shin TBC Presentation title TBC Masato Okada TBC Presentation title TBC Paul Bird

Objectives: Information coming soon. Agenda – Wednesday 30 October Workshop chairperson: Jose Paulo Lorenzo and E.I. Alekseeva TBC Presentation title TBC Zagrebneva Alena Igorevna TBC Presentation title TBC Alekseeva Ekaterina Ignatyevna TBC Presentation title TBC Serdal Uğurlu

Sponsored by AbbVie More information coming soon. Agenda – Thursday 29 October Workshop chairperson: Kichul Shin 1330-1440 Presentation title TBC Xenofon Baraliakos 1440-1455 Presentation title TBC Mitsumasa Kishimoto

Crossroads of Inflammation: What Advances in PsA/SpA Mean for Clinical Practice Objectives: The APEX study evaluated guselkumab in adults with active, erosive psoriatic arthritis and demonstrated meaningful clinical and radiographic benefits through Week 48. Participants met predefined activity and erosive criteria and were randomized to two guselkumab dosing regimens or placebo with crossover at Week 24. By Week 48, both guselkumab schedules showed sustained improvements in ACR20 and ACR50 responses, along with continued suppression of radiographic progression, while patients switched

Title coming soon Objectives: Agenda: Chairperson:Jose Paulo Lorenzo

Tacrolimus strategy for Autoimmune real-world in Rheumatic Disease Objectives: Agenda: Speakers:Jihyun Kang

The significance of IL-6 signal blocking in autoimmune diseases including RA Objectives: Information coming soon. Agenda – Wednesday 30 October Workshop chairpersons: Tsutomu Takeuchi and Sang-heon Lee TBC Presentation title TBC Chan-bum Choi TBC Presentation title TBC Ryu Watanabe

The workshop agenda and associated costs will be provided in due course. Synopsis Background & RationaleShared decision-making (SDM) is a key element of patient-centered care, enabling patients and clinicians to collaborate on making informed choices that align with patients’ values, preferences, and the best available evidence. Research shows that SDM improves engagement, satisfaction, outcomes, and may reduce unwarranted variation in care. In rheumatology, where treatment choices often involve necessary trade-offs (e.g., efficacy vs. safety, long-term monitoring, lifestyle impact), effective SDM
Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.